Clinical updates, including trial initiations, enrollment status and data readouts and publications: BMS, Dynavax, Evaxion, Macrogenics, Modag, Oramed, Palvella, Rakuten, Revive, Serum Institute of India, Spectrum, Supernus.

Biopharmas raising money in public or private financings, including: Arch, Cellectar, CNS, Cyclo, Epsilon Molecular, Genprex, Gracell, Greenwich, Gritstone, Inhibikase, Proteostasis, Transcenta, Vistagen, Yumanity.

New hires and promotions in the biopharma industry, including: Allakos, Cytomx, Haima, Iterum, Q32.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Biontech, Canbridge, Daiichi Sankyo, Esperion, Lumosa, Pfizer, Synairgen, Takeda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abpro, Aldeyra, Algernon, Ampio, Arca, Boehringer Ingelheim, Brii, Calcimedica, Cytodyn, Eusa, FSD, Glaxosmithkline, Hightide, Inotrem, Medincell, Mesoblast, Molecular, Ology, Regeneron, Taiwan Liposome, Valneva, Vasomune, Vir.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Clarity, HBM, Junshi, Phathom, Revitope Oncology, Sellas Life Sciences, Takeda.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 9 Meters, Abbvie, Abcellera, Aligos, Allecra, Anges, Aprinoia, Assertio, Astrazeneca, Aurinia, Avery, Biogen, Biomm, Biontech, Bio-Thera Solutions, Biovaxys Technology, Catalent, China Resources Sanjiu Medical & Pharmaceutical, Eisai, Eli Lilly, Emendobio, Enesi, Fosun, Greenwich Lifesciences, GT, Harbour Biomed, Hasten, Heat Biologics, Hitgen, Horizon, I Peace, Immuron, Inovio, Khondrion, Merck, Moderna, Nervgen, Novan, Novavax, Nyrada, Oncoceutics, Open Care, Ose Immunotherapeutics, Otsuka, PDS, Prime, Redhill, Regenacy, Scancell, Sciclone, Shanghai Haini, Shenzhen Hepalink, Shionogi, Takeda, Teijin, Transthera, Y-mabs.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Tessa, Xwpharma.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biolog-id, Biomérieux, Biointellisense, Brattle Street Investment, Change Healthcare, Cobham Advanced Electronic Solutions, Co-Diagnostics, Compugroup Medical, Dariohealth, Electrocore, Emd, Grove Biomedical, Hancock Jaffe Laboratories, Heru, Honeywell, Hyro, Intel, Nexus Dx, Osang Healthcare, Philips, Pro Medical Baltic, Purlab, Quest Diagnostics, Salona Global Medical Device, Siemens Healthineers, Spineway, Traction Guest, Twist Bioscience, Teladoc, World Telehealth Initiative, Zuora.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acell, Artms, Medtronic, Products + Features, Quidel, Rapid Medical.